EDITORIAL SECTION

Articles

The Impact of AI and Machine Learning on Drug Discovery

Now and then an industry hits a point where the old ways no matter how trusted start to feel a bit like trying to run a marathon in hiking boots Drug discovery is in that spot For decades pharmaceutical RD leaned heavily on long painstaking experiments and the occasional stroke of luck Entire teams would spend years nudging molecules around waiting for a hint that something might work After all th...

Advanced 3D Cell Models: Moving from Promise to Practice in Drug Discovery

Over the past decade organoids spheroids and other advanced D cell models have transformed how researchers approach disease modelling and drug development Their ability to better reflect human biology than traditional D cultures has generated significant enthusiasm across pharmaceutical research yet widespread adoption remains a work in progress

Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs

For most of the past ten years the prevailing strategy in immunooncology was addition Checkpoint blockade delivered durable remissions in a minority of patients the intuitive fix was to attach a second agent to a PD or PDL backbone and watch whether response rates moved

Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare

The healthcare industry is continually evolving driven by technological advancements and innovative approaches to patient care Among the most significant developments is the symbiotic relationship between medical devices

Virtual Webinars for Pharma Lead Generation: B2B Strategies 2026

In the changing environment of pharmaceutical marketing digital interactions have acquired the first place Although traditional facetoface conferences and trade show remain important virtual conferences are replacing them and at times complementing them Of them the pharma webinars have proven to be an effective approach to BB lead generation so pharmaceutical companies can connect with the audienc...

Prescription Drugs and Personalized Medicine: A New Era in Pharma

The field of medicine is rapidly evolving and one of the most exciting advancements is personalized medicine This approach tailors medical treatment to the individual characteristics of each patient

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys